Erick Messias

Refining Social Determinants of Suicide Risk Research To the Editor We read with great interest the recent study by Na et al1 on social determinants of health (SDOH) and suicide-related outcomes. This comprehensive review provides valuable insights into the role of SDOH in suicide risk, highlighting key factors that merit public health and policy attention. However, we believe that further discussion on methodological and theoretical aspects could strengthen the study’s implications.

1. Introduction In utero exposure to pharmaceutical compounds may impact fetal growth and postnatal health outcomes due to the fetus’s sensitivity to environmental factors, such as maternal drug use. Recent advances in pharmacovigilance and developmental biology have highlighted the complex interactions between maternal medication use and fetal development, revealing both immediate and long-term consequences that can extend well into adulthood [1,2].